Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Total Liabilities came in at $2.2 billion in Q2 2026, down 2.46% YoY from $2.2 billion in Q2 2025, and up 1.54% on a QoQ basis from $2.2 billion in Q1 2026.
Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Total Liabilities data on file, last reported at $2.2 billion in Q2 2026.
- Quarterly Total Liabilities fell 2.46% year-over-year to $2.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.2 billion (down 2.46% YoY) and the FY2025 annual result came in at $2.2 billion, down 2.91% from the prior year.
- Total Liabilities grew to $2.2 billion in Q2 2026, from $2.2 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $2.6 billion in Q1 2024 to a low of $945.3 million in Q4 2022.
- A 5-year average of $2.2 billion and a median of $2.2 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 177.0% — and 2024, when it retreated 19.22%.
- Tracing FTRE's Total Liabilities over 5 years: stood at $945.3 million in 2022, then jumped by 177.0% to $2.6 billion in 2023, then fell by 15.34% to $2.2 billion in 2024, then fell by 2.91% to $2.2 billion in 2025, then gained by 1.79% to $2.2 billion in 2026.
- The last three Total Liabilities figures came in at $2.2 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 2.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Bn |
| Mar 31, 2026 | 2.16 Bn |
| Dec 31, 2025 | 2.15 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.25 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 2.22 Bn |
| Sep 30, 2024 | 2.15 Bn |
| Jun 30, 2024 | 2.10 Bn |
| Mar 31, 2024 | 2.65 Bn |
| Dec 31, 2023 | 2.62 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Dec 31, 2022 | 945.30 Mn |